GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?
Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microenvironment biology, and the need for prospective trials.
LINK TO FULL TRANSCRIPT
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.